MedTrace Logo

Decision-making - the Benefit of Bedside CRP Within Ambulance Care

NCT04097210 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 110

Last updated 2022-01-31

No results posted yet for this study

Summary

Patients with degreased (DGC) for ambiguous reasons receive low triage priority. Their death risk is triple. Tools are needed to identify the critically ill patients from this group. The triage used today is not effective. The bedside point-of-care measurements are CRP, lactate acid and suPAR (Soluble Urokinase Plasminogen Activator Receptor). Elevated values associate with the probability of critical illness and predict a risk of death.

Conditions

  • Critical Illness

Interventions

DIAGNOSTIC_TEST

POC

Sponsors & Collaborators

  • Helsinki University Central Hospital

    lead OTHER

Principal Investigators

  • Maaret Castrén, Professor · Helsinki University Central Hospital

  • Johanna Kaartinen, PhD · Helsinki University Central Hospital

Eligibility

Min Age
16 Years
Max Age
104 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2021-06-01
Completion
2021-06-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04097210 on ClinicalTrials.gov